Company Omnicell, Inc.

Equities

OMCL

US68213N1090

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:00:00 2024-04-26 pm EDT 5-day change 1st Jan Change
27.86 USD +2.69% Intraday chart for Omnicell, Inc. +0.11% -25.96%

Business Summary

Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care through a portfolio of robotics, smart devices, intelligent software, and services. Its point of care automation solutions is designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company’s XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. For the operating room, the Company also offer specialized automated dispensing systems.

Number of employees: 3,650

Sales per Business

USD in Million2022Weight2023Weight Delta
Connected Devices, Software Licenses, and Other
54.4 %
828 63.9 % 624 54.4 % -24.68%
Technical Services
19.7 %
207 15.9 % 226 19.7 % +9.26%
Advanced Services
18.5 %
186 14.4 % 213 18.5 % +14.34%
Consumables
7.4 %
75 5.8 % 85 7.4 % +12.84%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
88.2 %
1,168 90.1 % 1,011 88.2 % -13.42%
Rest of World
11.8 %
128 9.9 % 136 11.8 % +6.25%

Managers

Managers TitleAgeSince
Chief Executive Officer 66 92-08-31
Director of Finance/CFO - 23-05-31
Chief Administrative Officer - 21-03-31
Chief Tech/Sci/R&D Officer - 18-05-31
Chief Operating Officer - 20-08-31
Investor Relations Contact - 20-09-30
Corporate Officer/Principal - 23-06-11
Human Resources Officer - 04-09-30
- -

Members of the board

Members of the board TitleAgeSince
Director/Board Member 68 12-12-31
Director/Board Member 68 13-12-31
Chief Executive Officer 66 92-08-31
Director/Board Member 65 21-07-06
Director/Board Member 64 19-03-17
Director/Board Member 63 12-05-21
Director/Board Member 68 19-05-13
Director/Board Member 65 22-05-23
Director/Board Member 55 23-07-05
- -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 56,206,492 45,248,499 ( 80.50 %) 10,283,000 ( 18.30 %) 80.50 %

Shareholders

NameEquities%Valuation
BlackRock Advisors LLC
16.40 %
7,530,809 16.40 % 220 M $
Vanguard Fiduciary Trust Co.
12.13 %
5,571,420 12.13 % 163 M $
2,012,411 4.382 % 59 M $
Champlain Investment Partners LLC
3.292 %
1,511,970 3.292 % 44 M $
BNY Mellon Investment Adviser, Inc.
2.807 %
1,289,263 2.807 % 38 M $
ClearBridge Investments LLC
2.582 %
1,185,967 2.582 % 35 M $
Eaton Vance Management
2.571 %
1,180,745 2.571 % 35 M $
Dimensional Fund Advisors LP
2.325 %
1,067,516 2.325 % 31 M $
Pacer Advisors, Inc.
2.304 %
1,058,027 2.304 % 31 M $
Geode Capital Management LLC
2.173 %
997,689 2.173 % 29 M $

Company contact information

Omnicell, Inc.

4220 North Freeway

76137, Fort Worth

+877 415 9990

http://www.omnicell.com
address Omnicell, Inc.(OMCL)

Group companies

NameCategory and Sector
Wholesale Distributors
Medical Specialties
Aesynt SRL
Wholesale Distributors
Medical Specialties
Financial Conglomerates
Industrial Machinery
Drugstore Chains
Omnicell India Pvt Ltd.
  1. Stock Market
  2. Equities
  3. OMCL Stock
  4. Company Omnicell, Inc.